These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31670756)

  • 1. The Oncology Care Model-Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment.
    Lyss AJ; Supalla SN; Schleicher SM
    JAMA Oncol; 2020 Aug; 6(8):1161-1162. PubMed ID: 31670756
    [No Abstract]   [Full Text] [Related]  

  • 2. Why oncologists need technology to succeed in alternative payment models.
    Fargnoli B; Holleran R; Kolodziej M
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP196-SP198. PubMed ID: 28665678
    [No Abstract]   [Full Text] [Related]  

  • 3. Value-based payment models in oncology: will they help or hinder patient access to new treatments?
    Shah S; Reh G
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP188-SP190. PubMed ID: 28665677
    [No Abstract]   [Full Text] [Related]  

  • 4. Hope and some skepticism whether oncology payment models will work.
    Inserro A
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP350-SP351. PubMed ID: 31860254
    [No Abstract]   [Full Text] [Related]  

  • 5. Can cancer care lead the way toward a value-based future?
    Macmillan K
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249
    [No Abstract]   [Full Text] [Related]  

  • 6. Squaring value-based payment with innovation in oncology.
    Caffrey M
    Am J Manag Care; 2018 Oct; 24(12 Spec No.):SP482-SP484. PubMed ID: 30550253
    [No Abstract]   [Full Text] [Related]  

  • 7. Value and payment for oncology in the United States.
    Robinson JC
    Ann Pharm Fr; 2013 Sep; 71(5):285-90. PubMed ID: 24075699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical oncologists' willingness to participate in bundled payment programs.
    Murciano-Goroff YR; McCarthy AM; Bristol MN; Domchek SM; Groeneveld PW; Motanya UN; Armstrong K
    BMC Health Serv Res; 2018 May; 18(1):391. PubMed ID: 29855315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community oncology in an era of payment reform.
    Cox JV; Ward JC; Hornberger JC; Temel JS; McAneny BL
    Am Soc Clin Oncol Educ Book; 2014; ():e447-52. PubMed ID: 24857138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncology care model and the future of alternative payment models: A gynecologic oncology perspective.
    Aviki EM; Schleicher SM; Boyd L; Liang M; Ko EM; Zanotti K; Moss H
    Gynecol Oncol; 2021 Sep; 162(3):529-531. PubMed ID: 34294415
    [No Abstract]   [Full Text] [Related]  

  • 11. Reforming the payment system for medical oncology.
    Bach PB
    JAMA; 2013 Jul; 310(3):261-2. PubMed ID: 23817729
    [No Abstract]   [Full Text] [Related]  

  • 12. The shortage of essential chemotherapy drugs in the United States.
    Gatesman ML; Smith TJ
    N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer clinical research: return on investment in the era of value-based purchasing.
    Holcombe RF
    J Oncol Pract; 2014 Sep; 10(5):327-8. PubMed ID: 24939181
    [No Abstract]   [Full Text] [Related]  

  • 14. Those Who Pay Have a Say: A View on Oncology Drug Pricing and Reimbursement.
    Newcomer LN
    Oncologist; 2016 Jul; 21(7):779-81. PubMed ID: 27325749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long battle over payment for oncology services in the office setting.
    Bailes JS; Coleman TS
    J Oncol Pract; 2014 Jan; 10(1):1-4. PubMed ID: 24443726
    [No Abstract]   [Full Text] [Related]  

  • 16. How to create successful alternative payment models in oncology.
    Miller HD
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673
    [No Abstract]   [Full Text] [Related]  

  • 17. Seeking value as cancer drug costs soar.
    Bender E
    Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value-based reimbursement in oncology.
    Kolodziej M; Hoverman JR
    Am J Manag Care; 2012 May; 18(3 Spec No.):SP124-6. PubMed ID: 22642278
    [No Abstract]   [Full Text] [Related]  

  • 19. Do oncologists believe new cancer drugs offer good value?
    Nadler E; Eckert B; Neumann PJ
    Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value in Oncology: It Is in the Eyes of the Beholder.
    Nabhan C; Phillips EG; Feinberg BA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):2-5. PubMed ID: 30659123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.